| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/04/2006 | US7022826 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits |
| 04/04/2006 | US7022821 Tumor Antigen Derived Gene-15 (TADG-15); a detectably labeled antibody specific for the TADG-15 protein which has a molecular size of 100 kDa and comprises CUB, LDLR and serine protease domains; useful in the diagnosis or treatment of breast and ovarian cancer in particular |
| 04/04/2006 | US7022820 Nucleotide sequences for use in the treatment and detection of tumor disorders |
| 04/04/2006 | US7022819 Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022817 Nucleotide sequence codin polypeptide for use in the diagnosis and treatment of nervous system and cancer disorders |
| 04/04/2006 | US7022816 Dopamine receptors and genes |
| 04/04/2006 | US7022815 truncated derivatives of PTH; have one of the following key substitutions: Ser3 --> Ala, Asn10 --> Ala or Gln; Leu11 --> Arg, Gly12 --> Ala and His14 --> Trp; use to treat bone disorders such as osteoporosis |
| 04/04/2006 | US7022676 obtained by hydrolysis of casein; hypotensive agentsl; for use in foods and drugs |
| 04/04/2006 | US7022673 Generation of biocompatible active macromolecules with amplified half-life; obtain macromolecule, couple to polymer, recover macromolecule |
| 04/04/2006 | US7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 04/04/2006 | US7022671 Surfactant protein C esters |
| 04/04/2006 | US7022670 nerve growth factors; for activating tyrosine kinase receptors |
| 04/04/2006 | US7022526 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 04/04/2006 | US7022513 Signal transduction; screening bactericides, viricides, fungicides, parasiticides |
| 04/04/2006 | US7022510 Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022499 Nucleic acids encoding differentiation inhibitor delta 2 |
| 04/04/2006 | US7022496 Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA |
| 04/04/2006 | US7022490 Myc-binding zinc finger proteins, their preparation and their use |
| 04/04/2006 | US7022489 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease |
| 04/04/2006 | US7022488 Functional coupling of T1Rs and T2Rs by Gi proteins, and cells-based assays for the identification of T1R and T2R modulators |
| 04/04/2006 | US7022487 Compositions and methods for regulating RNA stability using polypyrimidine tract proteins |
| 04/04/2006 | US7022485 immunogens or target antigens comprising citrullinated polypeptide derived from fragments of fibrinogen; prophylaxis of inflammatory disorders |
| 04/04/2006 | US7022482 Deactivation antigen protein; anticancer agents; Aids therapy |
| 04/04/2006 | US7022479 Detection of preferential biopolymers in sample; obtain sample mixture, incubate with binding reagent, form complexes, isolate bound complexes, amplify and detect signal tags |
| 04/04/2006 | US7022476 Calibrating test pattern; hybrid primers |
| 04/04/2006 | US7022474 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 04/04/2006 | US7022329 Using botulinum toxin |
| 04/04/2006 | US7022328 Therapeutic and diagnostic compositions |
| 04/04/2006 | US7022327 Recombinant birnavirus vaccine |
| 04/04/2006 | US7022326 Carboxymethylated retroviral regulatory proteins and interferon-α |
| 04/04/2006 | US7022325 Decapeptide immunogen able inducing cytotoxic lymphocytes, is used to provide a protection against an HIV infection; biodrugs |
| 04/04/2006 | US7022324 Stabilized viral envelope proteins and uses thereof |
| 04/04/2006 | US7022323 Prevent infections using envelope glycoprotein; binding to antibody |
| 04/04/2006 | US7022321 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
| 04/04/2006 | US7022319 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/04/2006 | CA2261315C Frozen food with antifreeze peptides |
| 04/04/2006 | CA2187207C Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/04/2006 | CA1341503C Molecular cloning and expression of human il-3 |
| 03/30/2006 | WO2006034454A1 Bcl-2 family member and bh-3 only proteins for use in development of peptidomimetics |
| 03/30/2006 | WO2006034292A2 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | WO2006034191A2 Tem17 binds to cortactin |
| 03/30/2006 | WO2006034106A2 Baff variants and methods therof |
| 03/30/2006 | WO2006033768A2 Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
| 03/30/2006 | WO2006033665A1 Tat-based vaccine compositions and methods of making and using same |
| 03/30/2006 | WO2006033481A1 Soluble toll-like receptor 4 protein |
| 03/30/2006 | WO2006033413A1 Method of quantifying peptide |
| 03/30/2006 | WO2006033368A1 METHOD OF DETECTING HEPATITIS B VIRUS s ANTIGEN |
| 03/30/2006 | WO2006033352A1 Antibacterial peptide and lactobacillus capable of producing the peptide |
| 03/30/2006 | WO2006033014A2 Modulation of flowering time and growth cessation in perennial plants |
| 03/30/2006 | WO2006032923A2 Inhibitors of protein kinase a anchoring |
| 03/30/2006 | WO2006032909A2 Pka ii anchoring disruption polypeptide |
| 03/30/2006 | WO2006032876A1 Mycer immortalized hepatocyte |
| 03/30/2006 | WO2006032781A2 Peptide derivatives, compositions and uses in therapeutic treatment of herpesvirus infection |
| 03/30/2006 | WO2006032697A2 MODIFIED VPl-CAPSID PROTEIN OF PARVOVIRUS B19 |
| 03/30/2006 | WO2006032499A1 Purification process for bacterial cytolysin |
| 03/30/2006 | WO2006032216A2 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 03/30/2006 | WO2006017749A3 Optimizing expression of active botulinum toxin type a |
| 03/30/2006 | WO2006013016A3 Diagnostics and therapeutics for diseases associated with eosinophil serine protease 1 (prss21) |
| 03/30/2006 | WO2006013014A3 Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) |
| 03/30/2006 | WO2006012451A3 Compositions and methods of use for mgd-csf in disease treatment |
| 03/30/2006 | WO2005123929A3 Plastid transit peptides |
| 03/30/2006 | WO2005121169A3 Apoptosis-inducing polypeptides |
| 03/30/2006 | WO2005117994A9 Bmp pathway methods and compositions |
| 03/30/2006 | WO2005113778A3 Maize multidrug resistance-associated protein polynucleotides and methods of use |
| 03/30/2006 | WO2005111065A3 Epitope-enhancement of a human cd4 hiv epitope |
| 03/30/2006 | WO2005106009A3 Lactoferrin cleavage of neisserial proteins |
| 03/30/2006 | WO2005105838A3 Ion channel |
| 03/30/2006 | WO2005103710A3 Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 1 (crhr1) |
| 03/30/2006 | WO2005099745A3 Gcp-170 fusion proteins and uses thereof |
| 03/30/2006 | WO2005098435A3 Peptides and peptidomimetics binding to cd23 |
| 03/30/2006 | WO2005090995A3 Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility |
| 03/30/2006 | WO2005082076A3 Methods for treating breast cancer using nrif3 related molecules |
| 03/30/2006 | WO2005071093A3 Chimpanzee adenovirus vaccine carriers |
| 03/30/2006 | WO2005068638A3 Promoter |
| 03/30/2006 | WO2005068494A3 Chimera botulinum toxin type e |
| 03/30/2006 | WO2005047546A3 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 03/30/2006 | WO2005040335A3 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto |
| 03/30/2006 | WO2005013898A3 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 03/30/2006 | WO2005002417A3 Cancer -linked gene aas target for chemotherapy |
| 03/30/2006 | WO2004039943A3 Human genes and gene expression products isolated from human prostate |
| 03/30/2006 | WO2004033651A3 Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| 03/30/2006 | WO2004020459A3 Secreted proteins |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060070144 comprising transforming plant cells with a polynucleotide linked to a promoter that regulates transcription of a nucleotide sequence that codes for protein which control flowering in plants |
| 03/30/2006 | US20060070141 Method of repressing flowering in a plant |
| 03/30/2006 | US20060070136 GLYT1 transgenic mouse |
| 03/30/2006 | US20060069517 three-dimensional structure to design a mutant of a protein belonging to the papain-like cysteine proteases; high degree of purity |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069243 Ovary-specific genes and proteins |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069241 Endocytosing delivery vehicle for targeting drugs and antibodies to prostate and other tissues |
| 03/30/2006 | US20060069240 Deposited in flat, structural platelets in reflective tissues of the squid Euprymna scolopes; protein-based reflectors in squids provide a striking example of nanofabrication in animal systems; modifying a refractive index of a reflectin |
| 03/30/2006 | US20060069239 Epididymis-specific gene as potential contraceptive target |
| 03/30/2006 | US20060069238 Synthetic glyco-lipo-peptides as vaccines |
| 03/30/2006 | US20060069058 Beta-sheet breaker peptide analogs that inhibit beta-pleated sheet formation in amyloid beta-peptide |
| 03/30/2006 | US20060069054 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |